Clinical Research Program Archives

Cluster of circulating tumor cells and white blood cells.

UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.

Human cells with acute myelocytic leukemia (AML) in the pericardial fluid, shown with an esterase stain at 400x magnification.

Joshua Zeidner, MD, and colleagues report that a combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia showed high rates of complete remission in an early-phase clinical trial.

Compilation of photos featuring UNC Lineberger researchers at poster sessions and presentations during the 2025 ASCO Annual Meeting.

UNC Lineberger faculty and trainees presented research findings and participated in panel discussions at the American Society of Clinical Oncology’s annual meeting in Chicago.

UNC faculty and trainees will share their latest research findings and clinical insights during talks, poster presentations and panel discussions during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.

Urologic oncologist Matthew Milowsky, MD, FASCO, discusses treatment options if you’ve been diagnosed with prostate cancer.

Tag: Clinical Research Program

UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer

ASCO Post: Revumenib in Triplet Regimen Under Study in Newly Diagnosed AML With NPM1/KMT2A Alterations

Novel drug combination is safe and benefits people with acute myeloid leukemia who have a specific genetic profile

UNC Lineberger faculty and trainees present research, receive honors at cancer research meeting

CURE: Delving into the Evaluation of JNJ-1900 Trial for Lung Cancer Treatment

UNC faculty and trainees to present at the world’s largest clinical cancer research meeting

MedPage Today: Survival in Small-Cell Lung Cancer Improved With Cytotoxic Add-On to Immunotherapy

What are my treatment options for prostate cancer?

WITN: Local cancer survivor and advocate speaks on Former President Biden’s latest diagnosis

ChosunBiz: Korean oncologist William Kim highlights immunotherapy’s role in cancer conquest